Femme et Homme
- | Pays :
- Spain
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the safety and tolerability of elotuzumab administered in combination with thalidomide and dexamethasone in the treatment of relapsed and/or refractory multiple myeloma.
Critère d'inclusion
- Relapsed and/or Refractory Multiple Myeloma